ACI Novel Therapeutic Modalities and Gene Therapies Conference

Loeb & Loeb LLP is proud to sponsor ACI's Novel Therapeutic Modalities and Gene Therapies Conference taking place from March 19-20, 2025, where Partner, Ryan Hagglund will be speaking on the panel “Redefining Due Diligence for Future-Forward Treatments: Tailoring Evaluation Strategies for Novel Drug Modalities”, and Associate, Dan Liu will be speaking on the panel "Lessons from the Latest mRNA and LNP Patent Litigation: Understanding How Ongoing and Potential Patent Wars Could Shape the Trajectory of Novel Therapeutics " on March 19.

From the event website:
This premier event brings together industry leaders to explore evolving market trends, regulatory frameworks, and IP strategies shaping the future of advanced therapeutics. From funding innovations and AI in drug discovery to navigating legal and compliance challenges, gain the insights you need to drive scientific advancements to global market success.

For more information, including how to register, please visit the event website.